Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|---|---|---|
| Revenue | revenue | 78.36B | 3.85% |
| Gross profit | profit | 3.59B | 17.27% |
| Total segment cost of goods sold | cost | 74.77B | 3.28% |
| Nonoperating income (expense) | revenue | 1.09B | 30538.44% |
| Total segment operating income | profit | 1.14B | 10.27% |
| Selling, general and administrative expense | cost | 1.98B | 23.59% |
| Acquisition and divestiture-related deal and integration expenses | cost | 164.16M | 65.19% |
| Depreciation, nonproduction | cost | 132.14M | 8.47% |
| Amortization expense | cost | 117.16M | -15.11% |
| Restructuring and other expenses, net | cost | 40.87M | -22.67% |
| Litigation and opioid-related expenses (credit), net | cost | 13.86M | 20.25% |
| Aggregate | revenue | 2.23B | |
| Income before income taxes | profit | 2.09B | 124.90% |
| Interest income (expense), nonoperating | revenue | 140.46M | 35.07% |
| Net income (loss) attributable to noncontrolling interest | cost | 11.80M | 2500.00% |
| Net income | profit | 1.63B | 127.14% |
| Income tax expense (benefit) | cost | 459.04M | 117.31% |
| Net income attributable to cencora, inc. | profit | 1.64B | 128.64% |
| Segment | Value | YoY |
|---|---|---|
| U.S. Healthcare Solutions | 68.77B | 2.91% |
| International Healthcare Solutions | 7.57B | 12.98% |
| Others | 2.03B | 4.51% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Accounts receivable, after allowance for credit loss, current | assets | 24.89B | |
| Inventories | assets | 20.01B | |
| Total assets held for sale | assets | 3.85B | |
| Cash and cash equivalents | assets | 2.18B | |
| Right to recover assets | assets | 1.57B | |
| Prepaid expenses and other | assets | 636.82M | |
| Total current assets | assets | 53.14B | |
| Goodwill | assets | 16.45B | |
| Other intangible assets | assets | 6.05B | |
| Other long-term assets | assets | 3.01B | |
| Property and equipment, net | assets | 2.81B | |
| Deferred income taxes | assets | 192.82M | |
| Total assets | assets | 81.65B | |
| Total current liabilities | liabilities | 56.13B | |
| Long-term debt | liabilities | 12.18B | |
| Accrued litigation liability | liabilities | 3.86B | |
| Other long-term liabilities | liabilities | 3.79B | |
| Total stockholders’ equity | liabilities | 3.58B | |
| Deferred income taxes | liabilities | 1.75B | |
| Accrued income taxes | liabilities | 352.77M | |
| Accounts payable, current | liabilities | 51.88B | |
| Accrued liabilities, current | liabilities | 3.20B | |
| Total liabilities held for sale | liabilities | 851.95M | |
| Short-term debt | liabilities | 202.66M | |
| Noncontrolling interests | liabilities | 187.36M | |
| Treasury stock, common, value | equity | 10.44B | |
| Accumulated other comprehensive income (loss), net of tax | equity | 961.31M | |
| Total cencora, inc. stockholders’ equity | equity | 3.40B | |
| Aggregate | equity | 14.80B | |
| Retained earnings (accumulated deficit) | equity | 8.49B | |
| Additional paid in capital, common stock | equity | 6.30B | |
| Common stock, value, issued | equity | 2.98M |
| Item | Value |
|---|---|
| Net income | 2.20B |
| Depreciation | 277.55M |
| Amortization | 249.70M |
| Impairment of assets, including goodwill | 249.50M |
| Provision for deferred income taxes | 192.77M |
| Adjustments to rca and oneoncology equity units | 97.58M |
| Share-based payment arrangement, noncash expense | 94.06M |
| Increase (decrease) in prepaid expense and other assets | 54.10M |
| Türkiye highly inflationary impact | 19.20M |
| Other noncash income (expense) | 1.04M |
| Accounts receivable, credit loss expense (reversal) | -4.87M |
| Equity investment, remeasurement gain (loss) | -10.50M |
| Gain (loss) on disposition of other assets | -36.05M |
| Income taxes payable and other liabilities | -91.90M |
| Increase (decrease) in inventories | -120.20M |
| Increase (decrease) in accrued liabilities | -257.39M |
| Lifo (credit) expense | -287.59M |
| Increase (decrease) in accounts receivable | -308.68M |
| Business combination, achieved in stages, preacquisition equity interest in acquiree, remeasurement, gain (loss) | -1.09B |
| Accounts payable | -2.19B |
| Item | Value |
|---|---|
| Proceeds from sale of assets | 43.77M |
| Payments for (proceeds from) notes receivable | 20.63M |
| Payment for (proceeds from) other investing activity | -2.38M |
| Payments to acquire equity method investments | -19.21M |
| Payments to acquire property, plant, and equipment | -284.99M |
| Net cash paid | -4.93B |
| Item | Value |
|---|---|
| Proceeds from lines of credit | 71.00B |
| Senior notes and loan borrowings | 4.65B |
| Proceeds from (payment for) other financing activity | -6.83M |
| Payment, tax withholding, share-based payment arrangement | -105.19M |
| Payments of ordinary dividends, common stock | -243.97M |
| Repayments of long-term debt | -349.49M |
| Repayments of lines of credit | -70.93B |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 4.39B |
| Cash and cash equivalents, end of period | 2.24B |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support